Palvella Therapeutics (PVLA) Total Current Liabilities (2016 - 2024)
Historic Total Current Liabilities for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to $4.3 million.
- Palvella Therapeutics' Total Current Liabilities fell 8526.29% to $4.3 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.3 million, marking a year-over-year decrease of 8526.29%. This contributed to the annual value of $2.4 million for FY2023, which is 9354.89% down from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Total Current Liabilities is $4.3 million, which was down 8526.29% from $6.3 million recorded in Q2 2024.
- Palvella Therapeutics' 5-year Total Current Liabilities high stood at $50.6 million for Q4 2021, and its period low was $2.4 million during Q4 2023.
- In the last 5 years, Palvella Therapeutics' Total Current Liabilities had a median value of $30.3 million in 2021 and averaged $27.7 million.
- Per our database at Business Quant, Palvella Therapeutics' Total Current Liabilities soared by 15243.05% in 2021 and then plummeted by 9354.89% in 2023.
- Palvella Therapeutics' Total Current Liabilities (Quarter) stood at $22.1 million in 2020, then surged by 128.32% to $50.6 million in 2021, then decreased by 27.65% to $36.6 million in 2022, then crashed by 93.55% to $2.4 million in 2023, then surged by 80.25% to $4.3 million in 2024.
- Its Total Current Liabilities stands at $4.3 million for Q3 2024, versus $6.3 million for Q2 2024 and $7.5 million for Q1 2024.